“Meaningful Use” Antimicrobial Use and Resistance (AUR)

For 2018, NHSN Antimicrobial Use (AU) and Antimicrobial Resistance (AR) (AUR) reporting have been identified as a new option for public health registry reporting under Meaningful Use Stage 3 (MU3). This measure applies to Eligible Hospitals.

Beginning January 1, 2017, a facility enrolled in the National Healthcare Safety Network (NHSN) will be able to register their intent to satisfy the AUR-MU3 objective. The NHSN user interface will include an AUR-MU3 registration page and allow the NHSN Facility Administrator to register AUR-MU3 intent. Active engagement for this MU3 objective includes monthly electronic reporting for a full calendar year of R1 Normative Antimicrobial Use Summary, Antimicrobial Resistance Event, and Antimicrobial Resistance Summary data in the format of Clinical Document Architecture (CDA) to NHSN.

Hospitals report healthcare-associated infection (HAI) data to the Virginia Department of Health (VDH) via NHSN.  More information on NHSN reporting to VDH can be found here, and general information on healthcare-associated infections and antimicrobial resistance can be found here.

Note: The use of the term “Meaningful Use” on VDH websites refers to the exchange of public health messaging with VDH for all CMS EHR Incentive Programs such as Promoting Interoperability, Meaningful Use, MIPS, or OPPS.


For questions, please contact the NHSN customer support desk at nhsncda@cdc.gov; please copy meaningfuluse@cdc.gov for tracking and follow-up.

Healthcare-Associated Infections and Antimicrobial Resistance Program:
(804) 864-8141


Page last modified: 6/29/2021 3:00PM